Viewing Study NCT04862650


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-28 @ 1:53 PM
Study NCT ID: NCT04862650
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-10
First Post: 2021-03-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: Marcelo Bonomi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 View
None Metastatic Head and Neck Squamous Cell Carcinoma View
None Metastatic Hypopharyngeal Squamous Cell Carcinoma View
None Metastatic Laryngeal Squamous Cell Carcinoma View
None Metastatic Oral Cavity Squamous Cell Carcinoma View
None Metastatic Oropharyngeal Squamous Cell Carcinoma View
None Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 View
None Recurrent Head and Neck Squamous Cell Carcinoma View
None Recurrent Hypopharyngeal Squamous Cell Carcinoma View
None Recurrent Laryngeal Squamous Cell Carcinoma View
None Recurrent Oral Cavity Squamous Cell Carcinoma View
None Recurrent Oropharyngeal Squamous Cell Carcinoma View
None Squamous Cell Carcinoma of Unknown Primary View
None Stage IV Hypopharyngeal Carcinoma AJCC v8 View
None Stage IV Laryngeal Cancer AJCC v8 View
None Stage IV Lip and Oral Cavity Cancer AJCC v8 View
None Stage IVA Hypopharyngeal Carcinoma AJCC v8 View
None Stage IVA Laryngeal Cancer AJCC v8 View
None Stage IVA Lip and Oral Cavity Cancer AJCC v8 View
None Stage IVB Hypopharyngeal Carcinoma AJCC v8 View
None Stage IVB Laryngeal Cancer AJCC v8 View
None Stage IVB Lip and Oral Cavity Cancer AJCC v8 View
None Stage IVC Hypopharyngeal Carcinoma AJCC v8 View
None Stage IVC Laryngeal Cancer AJCC v8 View
None Stage IVC Lip and Oral Cavity Cancer AJCC v8 View
Keywords: